Archer Daniels Midland Company (ADM) has had a prominent fluctuation in the biotech market with a series of significant financial actions and regulatory activities.
Munich Reinsurance Co Stock Corp in Munich invested a hefty $61.29 Million in the company while
Picton Mahoney Asset Management and JT Stratford LLC also made certain purchases.
Barclays, lifted their PT to $68 from $61 reflecting the project potential that ADM holds. Despite a recent financial setback upon settling of a $40 million with the U.S SEC, various expert assets like
DNB Asset Management AS and NEOS Investment Management LLC show unabated interest. New 12-month high records as well as
Earnings Beat amid an Accounting Probe highlight the market's optimistic response towards ADM.
Aberdeen Group plc and LSV Asset Management, however, sold a significant number of ADM shares. ADM is looking to form a joint venture to cut costs and reducing its 2025 profit outlook due to biofuel and trade uncertainty.
Archer Daniels Midland Company ADM News Analytics from Thu, 15 May 2025 15:31:51 GMT to Sat, 07 Mar 2026 12:32:36 GMT -
Rating 6
- Innovation 3
- Information 7
- Rumor -2
